RE:Question For BearsYes to every one of your questions.
Lumberfeverlong wrote: Do you have any basis for thinking Q3 will be a bad quarter and miss revised guidance in a substantial way? Do the WoW scripts data over the entire quarter indicate more erosion in their NA drugs? Are you aware of any new competition for any of their leading drugs? It is one thing for longs and bears to speculate, but does anyone have any hard facts that would point in one direction or another?